Early-Versus late-Onset systemic sclerosis: Differences in clinical presentation and outcome in 1037 patients

Medicine (United States)

Volumn 93, Issue 2, 2014, Pages 73-81

  Alba, Marco A ^a,b   Velasco, César ^b   Simeón, Carmen Pilar ^c   Fonollosa, Vicent ^c   Trapiella, Luis ^d   Egurbide, María Victoria ^e   Sáez, Luis ^f   Castillo, María Jesús ^g   Callejas, José Luis ^h   Camps, María Teresa ⁱ   Tolosa, Carles ^j   Ríos, Juan José ^k   Freire, Mayka ^l   Vargas, José Antonio ^m   Espinosa, Gerard ^a,b   Alonso, M ^l   Bernardino, J ^d   Bernardo, J ^d   Eguiluz, S ^e   Garcia F J ^g   Gil, A ^k   Gonzalez R ^g   Guillen A ^c   Mari B ^j   Martin N ^k   Perez I ⁱ   Rios R ^h   Rodriguez M ⁿ   Ruiz, M ^h   Soto, A ^l   Vallejo, C ^f   Velilla, J ^f   more..

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL DE CRUCES   (Spain)

^f HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^h HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

ⁱ HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^j Department of Internal Medicine Corporación Sanitaria Universitaria Parc Taulí ^*  (Spain)

^k HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^l UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^m HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

ⁿ HOSPITAL MÚTUA DE TERRASSA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACROOSTEOLYSIS; ADULT; ARTHRITIS; ARTICLE; CALCINOSIS; CAUSE OF DEATH; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; FINGER ULCER; FOLLOW UP; HEART CATHETERIZATION; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; HYPERTENSION; ISCHEMIA; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOSITIS; ONSET AGE; PERICARDITIS; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; STANDARDIZED MORTALITY RATIO; SURVIVAL TIME; SYSTEMIC SCLEROSIS; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGE OF ONSET; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 84900016172     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000018     Document Type: Article

References (58)

1. Abu-Shakra M, Lee P. Mortality in systemic sclerosis: A comparison with the general population. J Rheumatol. 1995;22:2100-2102
2. Amador-Patarroyo MJ, Rodriguez-Rodriguez A, Montoya-Ortiz G. How does age at onset influence the outcome of autoimmune diseases? Autoimmune Dis. 2012;2012:251730
3. Anonymous. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581-590
4. Anonymous. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur Respir J. 1989;2:561-585
5. Anonymous. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1990;141(5 Pt 2):S169-202
6. Arias-Nunez MC, Llorca J, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Martin J, et al. Systemic sclerosis in northwestern Spain: A 19-year epidemiologic study. Medicine (Baltimore). 2008;87:272-280
7. Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011;70:476-481
8. Avouac J, Guerini H, Wipff J, Assous N, Chevrot A, Kahan A, et al. Radiological hand involvement in systemic sclerosis. Ann Rheum Dis. 2006;65:1088-1092
9. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98-102
10. Breslow NE, Day NE. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1-406
11. Bryan C, Howard Y, Brennan P, Black C, Silman A. Survival following the onset of scleroderma: Results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol. 1996;35: 1122-1126
12. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: A systematic literature review. Semin Arthritis Rheum. 2008;37:223-235
13. Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M, et al. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: Data from the DUO Registry. Ann Rheum Dis. 2012;71:718-721
14. Derk CT, Artlett CM, Jimenez SA. Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: A nested case-control study. Clin Rheumatol. 2006;25:831-834
15. Elhai M, Meune C, Avouac J, Kahan A, Allanore Y. Trends in mortality in patients with systemic sclerosis over 40 years: A systematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2012;51:1017-1026
16. Foeldvari I, Tyndall A, Zulian F, Muller-Ladner U, Czirjak L, Denton C, et al. Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: Data from the EUSTAR database. Rheumatology (Oxford). 2012;51:1832-1837
17. Furberg CD, Manolio TA, Psaty BM, Bild DE, Borhani NO, Newman A, et al. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. Am J Cardiol. 1992;69:1329-1335
18. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989-2003
19. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34:1219-1263
20. Gates PE, Tanaka H, Graves J, Seals DR. Left ventricular structure and diastolic function with human ageing. Relation to habitual exercise and arterial stiffness. Eur Heart J. 2003;24:2213-2220
21. Haga HJ, Jonsson R. The influence of age on disease manifestations and serological characteristics in primary Sjogren?s syndrome. Scand J Rheumatol. 1999;28:227-232
22. Harrison BJ, Silman AJ, Symmons DP. Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors. Rheumatology (Oxford). 2000;39:112-113
23. Hedrich CM, Fiebig B, Hahn G, Suttorp M, Gahr M. Presentations and treatment of childhood scleroderma: Localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease. Clin Pediatr (Phila). 2011;50:604-614
24. Hissaria P, Lester S, Hakendorf P,Woodman R, Patterson K, Hill C, et al. Survival in scleroderma: Results from the population-based South Australian Register. Intern Med J. 2011;41:381-390
25. Hugle T, Schuetz P, Daikeler T, Tyndall A, Matucci-Cerinic M, Walker UA, et al. Late-onset systemic sclerosis-a systematic survey of the EULAR scleroderma trials and research group database. Rheumatology( Oxford). 2011;50:161-165
26. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: An international meta-analysis of individual patient data. Am J Med. 2005;118:2-10
27. Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol. 1998;37:750-755
28. Kitzman DW, Scholz DG, Hagen PT, Ilstrup DM, Edwards WD. Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc. 1988;63:137-146
29. Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud?s phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 2008;58:3902-3912
30. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778-799
31. LeRoy EC, Medsger TAJr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28:1573-1576
32. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001;44:735-736
33. Manno RL, Wigley FM, Gelber AC, Hummers LK. Late-age onset systemic sclerosis. J Rheumatol. 2011;38:1317-1325
34. Maricq HR, Spencer-Green G, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud?s syndrome and dermatomyositis. Am J Med. 1976;61:862-870
35. Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, Michon-Pasturel U, et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore). 1999;78:139-147
36. Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, et al. Systemic sclerosis in childhood: Clinical and immunologic features of 153 patients in an international database. Arthritis Rheum. 2006;54:3971-3978
37. Mayes MD, Lacey JVJr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246-2255
38. Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum. 2011;63:1182-1189
39. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res. 1991;68:1560-1568
40. Perez-Bocanegra C, Solans-Laque R, Simeon-Aznar CP, Campillo M, Fonollosa-Pla V, Vilardell-Tarres M. Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology (Oxford). 2010;49:1112-1117
41. Poormoghim H, Lucas M, Fertig N, Medsger TAJr. Systemic sclerosis sine scleroderma: Demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum. 2000;43:444-451
42. Prineas RJ, Le A, Soliman EZ, Zhang ZM, Howard VJ, Ostchega Y, et al. United States national prevalence of electrocardiographic abnormalities in black and white middle-age (45- to 64-year) and older (≥65-year) adults (from the Reasons for Geographic and Racial Differences in Stroke Study). Am J Cardiol. 2012;109: 1223-1228
43. Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus. 2000;9:96-100
44. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA. Age- and gender-related ventricular-vascular stiffening: A community-based study. Circulation. 2005;112:2254-2262
45. Rich S, Chomka E, Hasara L, Hart K, Drizd T, Joo E, et al. The prevalence of pulmonary hypertension in the United States. Adult population estimates obtained from measurements of chest roentgenograms from the NHANES II Survey. Chest. 1989;96:236-241
46. Schachna L, Wigley FM, Chang B, White B, Wise RA, Gelber AC. Age and risk of pulmonary arterial hypertension in scleroderma. Chest. 2003;124:2098-2104
47. Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, et al. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford). 2003;42:71-75
48. Simeon CP, Armadans L, Fonollosa V, Vilardell M, Candell J, Tolosa C, et al. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis. Ann Rheum Dis. 1997;56:723-728
49. Simeon-Aznar CP, Fonollosa-Pla V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, et al. Registry of the Spanish network for systemic sclerosis: Clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Rheum. 2012;41:789-800
50. Sunderkotter C, Herrgott I, Bruckner C, Moinzadeh P, Pfeiffer C, Gerss J, et al. Comparison of patients with and without digital ulcers in systemic sclerosis: Detection of possible risk factors. Br J Dermatol. 2009;160:835-843
51. Sunderkotter C, Riemekasten G. Pathophysiology and clinical consequences of Raynaud?s phenomenon related to systemic sclerosis. Rheumatology (Oxford). 2006;45(Suppl 3):iii33-5
52. Tiev KP, Diot E, Clerson P, Dupuis-Simeon F, Hachulla E, Hatron PY, et al. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: Post-hoc analysis of a nationwide multicenter cohort (ItinerAIR-Sclerodermie). J Rheumatol. 2009;36:1470-1476
53. Traub YM, Shapiro AP, Rodnan GP, Medsger TA, McDonald RH Jr, Steen VD, et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore). 1983;62:335-352
54. Valentini G, Vettori S, Cuomo G, Iudici M, DAbrosca V, Capocotta D, et al. Early systemic sclerosis: Short-term disease evolution and factors predicting the development of new manifestations of organ involvement. Arthritis Res Ther. 2012;14:R188
55. Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2007;66:754-763
56. Walker UA, Tyndall A, Czirjak L, Denton CP, Farge-Bancel D, Kowal-Bielecka O, et al. Geographical variation of disease manifestations in systemic sclerosis: A report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis. 2009;68:856-862
57. Weng HH, Ranganath VK, Oh M, Park GS, Khanna D, Clements PJ, et al. Differences in presentation of younger and older systemic sclerosis patients in clinical trials. Clin Exp Rheumatol. 2010;28(5 Suppl 62):S10-14
58. Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, et al. The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum. 2007;57: 203-212